Diphtheria tetanus toxoid and pertussis third-dose (DTP3) in New Zealand
New Zealand: Diphtheria tetanus toxoid and pertussis third-dose (DTP3) was 88.0% in 2025. ▬ Flat
Diphtheria tetanus toxoid and pertussis third-dose (DTP3) in New Zealand, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for diphtheria tetanus toxoid and pertussis third-dose (dtp3) in New Zealand is 88.0%, measured in 2025. That is the lowest value across all 26 years on record.
That represents a change of down 1.1% on the previous year and down 4.3% over ten years.
Over the whole period, diphtheria tetanus toxoid and pertussis third-dose (dtp3) in New Zealand peaked at 95.0% in 2011 and was at its lowest, 88.0%, in 2007.
That places New Zealand 112th out of 194 countries with data for 2025, putting it in the middle of the range.
Diphtheria tetanus toxoid and pertussis third-dose (DTP3) in New Zealand, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 90.0% | — |
| 2001 | 90.0% | +0.0% |
| 2002 | 90.0% | +0.0% |
| 2003 | 90.0% | +0.0% |
| 2004 | 89.0% | -1.1% |
| 2005 | 89.0% | +0.0% |
| 2006 | 89.0% | +0.0% |
| 2007 | 88.0% | -1.1% |
| 2008 | 89.0% | +1.1% |
| 2009 | 92.0% | +3.4% |
| 2010 | 93.0% | +1.1% |
| 2011 | 95.0% | +2.2% |
| 2012 | 93.0% | -2.1% |
| 2013 | 92.0% | -1.1% |
| 2014 | 93.0% | +1.1% |
| 2015 | 92.0% | -1.1% |
| 2016 | 92.0% | +0.0% |
| 2017 | 94.0% | +2.2% |
| 2018 | 93.0% | -1.1% |
| 2019 | 92.0% | -1.1% |
| 2020 | 92.0% | +0.0% |
| 2021 | 90.0% | -2.2% |
| 2022 | 89.0% | -1.1% |
| 2023 | 88.0% | -1.1% |
| 2024 | 89.0% | +1.1% |
| 2025 | 88.0% | -1.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 89.6% | 88.0% | 92.0% | 10 |
| 2010s | 92.9% | 92.0% | 95.0% | 10 |
| 2020s | 89.3% | 88.0% | 92.0% | 6 |
Countries ranked near New Zealand
More health data for New Zealand
- Un projection of annual infant deaths, annual growth rate -2.94 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.4815 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,116 deaths per 1,000 people (2090)
- Number of infants who die before age 1 33 deaths (2100)
- Population ages 60-64, female, annual growth rate 0.2856 % change on previous year (2025)
- Population ages 60-64, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, female, per capita 0.0313 units per person (2025)
- Population ages 60-64, male, annual growth rate 0.3541 % change on previous year (2025)
- Population ages 60-64, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, male, per capita 0.0292 units per person (2025)
Frequently asked questions
- What is diphtheria tetanus toxoid and pertussis third-dose (dtp3) in New Zealand?
- Diphtheria tetanus toxoid and pertussis third-dose (dtp3) in New Zealand was 88.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest diphtheria tetanus toxoid and pertussis third-dose (dtp3) recorded in New Zealand?
- The highest recorded value was 95.0% in 2011.
- What is the lowest diphtheria tetanus toxoid and pertussis third-dose (dtp3) recorded in New Zealand?
- The lowest recorded value was 88.0% in 2007.
- How does New Zealand rank for diphtheria tetanus toxoid and pertussis third-dose (dtp3)?
- New Zealand ranks 112th out of 194 countries with data for 2025.
- Is diphtheria tetanus toxoid and pertussis third-dose (dtp3) rising or falling in New Zealand?
- Over the last ten years it is down 4.3%. The long-run trend across the full record is flat.
- Where does this New Zealand data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Diphtheria tetanus toxoid and pertussis third-dose (DTP3) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).